Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 06, 2020

SELL
$7.5 - $11.11 $249,435 - $369,496
-33,258 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$8.33 - $13.79 $277,039 - $458,627
33,258 New
33,258 $350,000
Q3 2018

Nov 08, 2018

SELL
$9.54 - $13.87 $19 - $27
-2 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$13.3 - $17.49 $26 - $34
2 New
2 $0

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.